The successful use of electroconvulsive therapy in a patient with interferon-induced psychotic depression.
We report the successful use of electroconvulsive therapy in a patient who developed major depression with psychotic features while being treated with interferon alfa-2b for hepatitis C. We reviewed the literature of similar cases and discuss treatment options for interferon-induced depression and psychosis.
Zincke
Miriam Tanja
MT
University of Medicine and Dentistry of New Jersey--New Jersey Medical School, Newark, NJ 07103, USA.
Kurani
Amit
A
Istafanous
Rafik
R
Kellner
Charles
C
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003865:Major Depressive Disorder / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy*; D004565:Electroconvulsive Therapy; D004569:Electroencephalography / Q000187:drug effects; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011092:Polyethylene Glycols; D011605:Psychoses, Substance-Induced / Q000175:diagnosis / Q000628:therapy*; D011994:Recombinant Proteins; D019233:Retreatment; D016896:Treatment Outcome
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C417083:peginterferon alfa-2b